<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="pmc">PeerJ</journal-id>
      <journal-id journal-id-type="nlm-ta">PeerJ</journal-id>
      <journal-id journal-id-type="publisher-id">PeerJ</journal-id>
      <journal-title-group>
        <journal-title>PeerJ</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2167-8359</issn>
      <publisher>
        <publisher-name>PeerJ Inc.</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">73</article-id>
      <article-id pub-id-type="doi">10.7717/peerj.73</article-id>
      <article-categories>
        <subj-group subj-group-type="categories">
          <subject>Biochemistry</subject>
          <subject>Biophysics</subject>
          <subject>Neuroscience</subject>
          <subject>Cognitive Disorders</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib id="author-1" contrib-type="author">
          <name>
            <surname>Ryan</surname>
            <given-names>Timothy M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <contrib id="author-2" contrib-type="author">
          <name>
            <surname>Caine</surname>
            <given-names>Joanne</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
        </contrib>
        <contrib id="author-3" contrib-type="author">
          <name>
            <surname>Mertens</surname>
            <given-names>Haydyn D.T.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-3">3</xref>
        </contrib>
        <contrib id="author-4" contrib-type="author">
          <name>
            <surname>Kirby</surname>
            <given-names>Nigel</given-names>
          </name>
          <xref ref-type="aff" rid="aff-3">3</xref>
        </contrib>
        <contrib id="author-5" contrib-type="author">
          <name>
            <surname>Nigro</surname>
            <given-names>Julie</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
        </contrib>
        <contrib id="author-6" contrib-type="author">
          <name>
            <surname>Breheney</surname>
            <given-names>Kerry</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
        </contrib>
        <contrib id="author-7" contrib-type="author">
          <name>
            <surname>Waddington</surname>
            <given-names>Lynne J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
        </contrib>
        <contrib id="author-8" contrib-type="author">
          <name>
            <surname>Streltsov</surname>
            <given-names>Victor A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
        </contrib>
        <contrib id="author-9" contrib-type="author">
          <name>
            <surname>Curtain</surname>
            <given-names>Cyril</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <contrib id="author-10" contrib-type="author">
          <name>
            <surname>Masters</surname>
            <given-names>Colin L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <contrib id="author-11" contrib-type="author" corresp="yes">
          <name>
            <surname>Roberts</surname>
            <given-names>Blaine R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
          <email>blaine.roberts@florey.edu.au</email>
        </contrib>
        <aff id="aff-1"><label>1</label><institution>The Florey Institute of Neuroscience and Mental Health, University of Melbourne</institution>, <addr-line>Parkville, Victoria</addr-line>, <country>Australia</country></aff>
        <aff id="aff-2"><label>2</label><institution>Materials Science and Engineering, Preventative Health Flagship, Commonwealth Scientific and Industrial Research Organization</institution>, <addr-line>Parkville, Victoria</addr-line>, <country>Australia</country></aff>
        <aff id="aff-3"><label>3</label><institution>SAXS/WAXS Beamline, Australian Synchrotron</institution>, <addr-line>Clayton, Victoria</addr-line>, <country>Australia</country></aff>
      </contrib-group>
      <contrib-group content-type="editors">
        <contrib id="editor-1" contrib-type="editor">
          <name>
            <surname>Schweitzer-Stenner</surname>
            <given-names>Reinhard</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2013-05-07">
        <day>7</day>
        <month>5</month>
        <year iso-8601-date="2013">2013</year>
      </pub-date>
      <volume>1</volume>
      <elocation-id>e73</elocation-id>
      <history>
        <date date-type="received" iso-8601-date="2012-11-22">
          <day>22</day>
          <month>11</month>
          <year iso-8601-date="2012">2012</year>
        </date>
        <date date-type="accepted" iso-8601-date="2013-04-22">
          <day>22</day>
          <month>4</month>
          <year iso-8601-date="2013">2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2013 Ryan et al.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Ryan et al.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://peerj.com/articles/73"/>
      <abstract>
        <p>Alzheimer’s disease is the leading cause of dementia in the elderly. Pathologically it is characterized by the presence of amyloid plaques and neuronal loss within the brain tissue of affected individuals. It is now widely hypothesised that fibrillar structures represent an inert structure. Biophysical and toxicity assays attempting to characterize the formation of both the fibrillar and the intermediate oligomeric structures of Aβ typically involves preparing samples which are largely monomeric; the most common method by which this is achieved is to use the fluorinated organic solvent 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP). Recent evidence has suggested that this method is not 100% effective in producing an aggregate free solution. We show, using dynamic light scattering, size exclusion chromatography and small angle X-ray scattering that this is indeed the case, with HFIP pretreated Aβ peptide solutions displaying an increased proportion of oligomeric and aggregated material and an increased propensity to aggregate. Furthermore we show that an alternative technique, involving treatment with strong alkali results in a much more homogenous solution that is largely monomeric. These techniques for solubilising and controlling the oligomeric state of Aβ are valuable starting points for future biophysical and toxicity assays.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Amyloid</kwd>
        <kwd>Hexafluoroisopropanol</kwd>
        <kwd>Ammonium Hydroxide</kwd>
        <kwd>Aggregation</kwd>
        <kwd>A β</kwd>
        <kwd>A β toxicity</kwd>
        <kwd>Oligomers</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="fund-1">
          <funding-source>NHMRC program grant</funding-source>
        </award-group>
        <award-group id="fund-2">
          <funding-source>Victorian government’s operational support program</funding-source>
        </award-group>
        <funding-statement>Funding was provided by CSIRO, a NHMRC program grant, and the Victorian government’s operational support program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Alzheimer’s disease is the leading cause of dementia in the elderly human population. This disease is characterised by neurofibrillary tangles, neuronal death, synapse dysfunction and formation of extracellular amyloid aggregates, ultimately leading to cognitive decline and dementia. Amyloid formation by Aβ peptides is characteristic of the disease, forming the major constituent of the plaques that are symptomatic of Alzheimer’s disease (<xref ref-type="bibr" rid="ref-19">Glenner &amp; Wong, 1984</xref>; <xref ref-type="bibr" rid="ref-34">Masters et al., 1985</xref>). However, the formation of these fibrillar structures is not well correlated with disease severity (<xref ref-type="bibr" rid="ref-36">McLean et al., 1999</xref>), indicating that fibrils represent a relatively non-toxic endpoint in a toxic aggregation pathway (<xref ref-type="bibr" rid="ref-36">McLean et al., 1999</xref>). To reconcile these observations several theories suggesting the presence of soluble, small, oligomeric species of Aβ have been developed (<xref ref-type="bibr" rid="ref-28">Kirkitadze, Bitan &amp; Teplow, 2002</xref>).</p>
      <p>There are a number methods for generating small toxic oligomers <italic>in vitro</italic> (for examples see (<xref ref-type="bibr" rid="ref-50">Sahoo et al., 2009</xref>; <xref ref-type="bibr" rid="ref-61">Yu et al., 2009</xref>; <xref ref-type="bibr" rid="ref-1">Ahmed et al., 2010</xref>; <xref ref-type="bibr" rid="ref-48">Ryan et al., 2010</xref>)), but typically most of these preparations involve the preliminary generation of a stock of Aβ which is largely monomeric (<xref ref-type="bibr" rid="ref-54">Stine et al., 2003</xref>). Generally this is a critical requirement for many kinetic studies, as solutions which contain a large number of aggregates will have adverse impacts on understanding how an unfolded form of Aβ self-associates into a small nucleus which then elongates into fibrillar structures (<xref ref-type="bibr" rid="ref-54">Stine et al., 2003</xref>; <xref ref-type="bibr" rid="ref-55">Teplow, 2006</xref>). Unfortunately, this is not a simple process of resuspending lyophilised peptide in the desired buffer, as the hydrophobic nature of the peptide makes the initial dissolution very difficult (<xref ref-type="bibr" rid="ref-55">Teplow, 2006</xref>). Furthermore Aβ appears to have a structural memory, reforming the conformations that it had adopted prior to lyophilisation (<xref ref-type="bibr" rid="ref-54">Stine et al., 2003</xref>).</p>
      <p>To avoid these issues many researchers resort to a variety of solubilisation agents, including strong alkali and acids (<xref ref-type="bibr" rid="ref-63">Zagorski et al., 1999</xref>; <xref ref-type="bibr" rid="ref-16">Fezoui et al., 2000</xref>; <xref ref-type="bibr" rid="ref-55">Teplow, 2006</xref>), dimethylsulfoxide (DMSO) (<xref ref-type="bibr" rid="ref-51">Shen &amp; Murphy, 1995</xref>; <xref ref-type="bibr" rid="ref-31">Lambert et al., 2001</xref>; <xref ref-type="bibr" rid="ref-5">Broersen et al., 2011</xref>), chaotropic salts and fluorinated alcohols, such as trifluroethanol (<xref ref-type="bibr" rid="ref-62">Zagorski &amp; Barrow, 1992</xref>) and hexafluoroisopropanol (HFIP) (<xref ref-type="bibr" rid="ref-54">Stine et al., 2003</xref>; <xref ref-type="bibr" rid="ref-5">Broersen et al., 2011</xref>). The most commonly adopted approach is to use HFIP (thought to induce alpha helical conformations, produce monomeric solutions and remove the conformational memory from the peptide) followed by removal of HFIP and resuspension using an aqueous compatible resuspension solvent such as DMSO (<xref ref-type="bibr" rid="ref-56">Walsh et al., 1997</xref>; <xref ref-type="bibr" rid="ref-54">Stine et al., 2003</xref>; <xref ref-type="bibr" rid="ref-59">Williams, Day &amp; Serpell, 2010</xref>). Recently, the use of HFIP has been suggested by a number of groups to cause heterogeneity in the starting peptide self-association state (<xref ref-type="bibr" rid="ref-38">Nichols et al., 2005a</xref>; <xref ref-type="bibr" rid="ref-39">Nichols et al., 2005b</xref>; <xref ref-type="bibr" rid="ref-40">Pachahara et al., 2012</xref>), which may cause enhanced aggregation.</p>
      <p>We show using a variety of methods, including thioflavin T (ThT) binding, Small Angle X-ray scattering (SAXS), dynamic light scattering (DLS) and size exclusion chromatography measurements, that HFIP pretreatment affects the aggregation state and kinetics of amyloid formation of the resuspended peptide. We also show that the use of ammonium hydroxide, as an initial treatment, greatly aids solubility and produces a relatively less aggregated and seed free peptide solution, which is important for understanding the process of Aβ self-association and hence neuronal cell toxicity.</p>
    </sec>
    <sec sec-type="materials">
      <title>Materials</title>
      <p>Human Aβ<sub>1–42</sub> (from this point referred to as Aβ<sub>42</sub>) was synthesised and purified by Dr. James I. Elliott at Yale University (New Haven, CT) using tBOC chemistry with DCC and HOBT coupling reagents. The correct unmodified sequence was verified by mass spectrometry. 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) was obtained from Oakwood Products Inc. (West Columbia, SC), analytical grade ammonium hydroxide (<named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content>) (28% v/v), trifluoroacetic acid (TFA, 99%) and staurosporine from <italic>Streptomyces</italic> sp. were from Sigma Chemical Co (St Louis, MO). Poly-L-lysine coated 96-well plates were from BD (Franklin Lakes, NJ Cat. No. 356516). The F12K media, horse serum, penicillin, streptomycin, amphotericin B and trypsin/EDTA were from Invitrogen (Grand Island, NY). Foetal bovine serum (FBS) was from SAFC Biosciences (Lenexa, KS). Human recombinant β-nerve growth factor (NGF) was purchased from Sino Biological Inc. (Beijing, P.R. China). The cell counting kit-8 (CCK-8) reagent was from Dojindo Molecular Technologies, Inc. (Kumamoto, Japan). All reagents otherwise not indicated were of analytical grade.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Aβ HFIP and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreatment</title>
        <p>Synthetic human Aβ<sub>42</sub> peptide was prepared in two separate ways. Firstly the Aβ<sub>42</sub> lyophilised powder was dissolved in TFA and dried under a nitrogen stream. The remaining film was dissolved in 100% HFIP to a concentration of 1 mg/ml, sonicated 5 min in a bath sonicator and dried under a nitrogen stream. The HFIP treatment was repeated twice more and on final dissolving the peptide was dispensed into microcentrifuge tubes. After drying under a nitrogen stream, the peptide was further dried under vacuum for 1–2 h to give a clear film.</p>
        <p>The second method was to take the original peptide and dissolve it in 10% (w/v) <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> at 0.5 mg/ml. The peptide was incubated for 10 min at room temperature followed by sonication (5 min) and then dispensed (0.5 ml) into microfuge tubes. The <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> was removed by lyophilisation to yield a salt free fluffy white peptide. All aliquots from both methods were then stored at −80°C. Immediately prior to use, the HFIP- and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content>-treated and untreated Aβ<sub>42</sub> were dissolved in 60 mM NaOH and the concentration determined by absorbance at 214 and 280 nm using extinction coefficients of 76848 M<sup>-1</sup> cm<sup>-1</sup> or 1490 M<sup>-1</sup> cm<sup>-1</sup>, respectively. In all cases the resuspended peptide was analysed by mass spectrometry and the peptide found to be unmodified with no trace of HFIP or <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content>.</p>
      </sec>
      <sec>
        <title>Thioflavin T assay</title>
        <p>The ThT assays were conducted as described previously (<xref ref-type="bibr" rid="ref-35">McColl et al., 2009</xref>; <xref ref-type="bibr" rid="ref-49">Ryan et al., 2012</xref>), Briefly, Aβ<sub>42</sub> reconstituted in 60 mM NaOH to a stock concentration ∼200 µM was diluted to a final concentration of 5 µM in phosphate buffered saline (PBS, 136.89 mM NaCl, 2.68 mM KCl, 6.39 mM <named-content content-type="chemical-compound">Na<sub>2</sub>PO<sub>4</sub></named-content>, 1.47 mM <named-content content-type="chemical-compound">KH<sub>2</sub>PO<sub>4</sub></named-content>) pH 7.4 containing 30 µM ThT. Vehicle controls of 60 mM NaOH were used to confirm that the typical dilution of between 1 in 50 to 1 in 200 did not significantly alter the pH of the PBS solution. The samples were dispensed (200 µl) into a 96 well clear bottom plate and placed in a Flexstation 3 plate reader (Molecular Devices, Sunnyvale, CA), incubated at 37°C with agitation every 7 min. The ThT fluorescence was measured every 7 min for 24 h using excitation and emission wavelengths of 440 nm and 485 nm, respectively.</p>
      </sec>
      <sec>
        <title>Transmission Electron Microscopy (TEM)</title>
        <p>Carbon-coated 300-mesh copper grids were glow-discharged in nitrogen to render the carbon film hydrophilic. Samples were gently agitated, before pipetting (4 µl) onto the grids. After 30 s adsorption time, the excess was drawn off using Whatman 541 filter paper. The grids were stained with 2% w/v potassium phosphotungstate, pH 7.2, for 10 s. Grids were air-dried before examination. The samples were examined using a Tecnai 12 Transmission Electron Microscope (FEI, Eindhoven, The Netherlands) at an operating voltage of 120 KV. Images were recorded using a Megaview III CCD camera and AnalySIS camera control software (Olympus).</p>
      </sec>
      <sec>
        <title>Dynamic light scattering</title>
        <p>For dynamic light scattering (DLS) experiments the Aβ<sub>42</sub> dissolved in 60 mM NaOH (Stock concentration 500 µM) was diluted into 50 mM Tris pH 8.0 buffer containing 10 mM EDTA to a final concentration of 100 µM. This buffer was chosen to minimise aggregation as Aβ aggregates at a slower rate at this pH and EDTA was included to prevent metal induced aggregation (<xref ref-type="bibr" rid="ref-22">Huang et al., 2004</xref>). Thus, the aggregation state of the resuspended material was not expected to change significantly during the time taken to prepare the peptide for DLS measurements. Vehicle controls were prepared at the concentrations used in the Aβ<sub>42</sub> experiments. The pH of all reactions were checked to be pH 8.0. All reaction mixtures were filtered through a 0.2 µm syringe filter before the concentration of the sample was measured to determine the degree of peptide loss during filtration. In all cases the concentration of peptide changed less than 5%. Subsequently, 20 µl of the filtrate was loaded in quadruplicate into a Greiner 384-well low volume glass bottom plate. The plate was centrifuged (5 min, 1000 × g) to pellet any remaining larger insoluble material prior to measurement. A total time of 20 min elapsed between the addition of the Aβ<sub>42</sub> to the buffer and the acquiring of data from the plate.</p>
        <p>The DLS measurements were taken at 25°C using a Dyna Pro Nano Star plate reader at the Bio21 Collaborative Crystallisation Centre at laser wavelength 830 nm, with temperature control capacity and auto-attenuation function. To ensure accurate readings, the final distribution was taken from an accumulation of 50 individual, 5 s DLS collections. Hydrodynamic radius (<italic>R</italic><sub><italic>h</italic></sub>) was calculated from the diffusion coefficient by the Stokes–Einstein relationship.</p>
      </sec>
      <sec>
        <title>Size Exclusion Chromatography (SEC)</title>
        <p>For SEC measurements the Aβ<sub>42</sub> stock in 60 mM NaOH was diluted into PBS to a final concentration of 200 µM and incubated at 25°C for 20 min. The samples were centrifuged (5 min, 16,500 × g) immediately before loading onto a S200 Superdex column (GE, 10/300 GL). The column was eluted with 50 mM Tris pH 8.0 at a flow rate of 0.5 ml/min for 1.5 column volumes. The elution of proteins was measured using a flow cell absorbance detector set at 280 nm. Molecular weight was estimated by comparison to the SEC protein calibrants (GE Healthcare).</p>
      </sec>
      <sec>
        <title>Small-angle X-ray scattering (SAXS) measurements</title>
        <p>A slightly modified approach for solubilising the treated Aβ<sub>42</sub> was used for SAXS measurements, whereby the lyophilised peptide (either treated with HFIP or <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content>, and typically in 3–4 mg aliquots) was taken up in 20 µl of 60 mM NaOH, which was immediately diluted to 13 mM NaOH with distilled water. This sample was sonicated for 5 min in a bath sonicator to ensure the peptide entered the solution at the lower concentration of NaOH. The sample was then neutralised with 10X PBS, resulting in a solution with a pH of 7.4 and centrifuged at 16,500 × g in a benchtop microcentrifuge for 10 min. The 214 nm absorbance of the supernatant was measured to determine concentration using the above quoted extinction coefficient. Typically this process resulted in stock solutions of approximately 5–7 mg/ml (1300–1500 µM). No differences in the kinetics of fibril formation, as measured by ThT fluorescence, were observed for direct dilution from 60 mM NaOH or 13 mM NaOH.</p>
        <p>SAXS measurements were acquired at the SAXS/WAXS beamline of the Australian Synchrotron (Clayton, Victoria, Australia). Aβ<sub>42</sub> solutions, made using untreated, HFIP treated and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> treated lyophilised peptide, solubilised using the above described NaOH solubilisation protocol (1 mg/ml, 221 µM) were analysed at a camera length of 3.3 m corresponding to a range of momentum transfer 0.005 ≤ <italic>q</italic> ≤ 0.35 Å<sup>−1</sup> (where <italic>q</italic> = 4πsinθ/λ, 2θ is the scattering angle and λ is the X-ray wavelength: 1.03 Å at 12 KeV), using a Pilatus 1 M camera (Dectris, Switzerland). Data were normalised using an integrated beamstop and intensities put on an absolute scale using distilled water as a standard. To limit radiation damage, 50 µl samples/buffers were flowed through a 1.5 mm quartz capillary and 10 frames of 1 s exposure collected. The individual frames were compared for agreement before being averaged with the scatterBrain IDL program, downloaded from the Australian synchrotron SAXS/WAXS beam line website (<uri xlink:href="http://www.synchrotron.org.au/">http://www.synchrotron.org.au/</uri>).</p>
        <p>SAXS data were analysed using Primus (<xref ref-type="bibr" rid="ref-29">Konarev et al., 2003</xref>) from the ATSAS (<xref ref-type="bibr" rid="ref-44">Petoukhov et al., 2007</xref>; <xref ref-type="bibr" rid="ref-43">Petoukhov et al., 2012</xref>) software suite (<uri xlink:href="http://www.embl-hamburg.de/biosaxs/software.html">www.embl-hamburg.de/biosaxs/software.html</uri>), which was used to plot the data and create Kratky plots. A Kratky plot, is a plot of Intensity (I) multiplied by the square of the scattering vector, <italic>s</italic>, (defined as equal to 4πsin(θ)/λ, where 2θ is the total scattering angle and λ is the wavelength of the X-ray) against <italic>s</italic> (<xref ref-type="bibr" rid="ref-13">Doniach, 2001</xref>).</p>
      </sec>
      <sec>
        <title>Aβ<sub>1-42</sub> toxicity in cell culture</title>
        <p>Rat pheochromocytoma (PC12) cells were maintained and passaged every 3–4 days in PC12 media (F12K media containing 15% (v/v) horse serum, 2.5% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate and 0.25 µg/ml amphotericin B. The PC12 cells (passage 5–15) were trypsinised (0.05% (w/v) trypsin/0.48 mM EDTA in PBS) and harvested in the maintenance media. The cells were centrifuged (400 × g, 5 min) and the cell pellet was resuspended in F12K media containing 0.5% (v/v) FBS, 100 U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate and 0.25 µg/ml amphotericin B). The centrifugation step was repeated and the cell pellet was resuspended in the media containing 0.5% (v/v) FBS with the addition of 100 ng/ml NGF. The cells were seeded at 5 × 10<sup>3</sup> cells/well (100 µl/well) into the inner 60 wells of a 96-well plate coated with poly-L-lysine. The outer 36 wells were used as a moat and were filled with sterile water (100 µl/well). The cultures were maintained at 37°C with 5% <named-content content-type="chemical-compound">CO<sub>2</sub></named-content> in a humidified incubator (Heraeus Hera cell 150, Kendro Laboratory Products, Langenselbold, Germany) and allowed to differentiate for 96 h before treating with Aβ<sub>42</sub>.</p>
        <p>The HFIP- or <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content>-treated peptide were prepared as described for the SAXS measurements, except 0.5 mg of Aβ was reconstituted using 60 mM NaOH, sterile water and 10 × Dulbecco’s PBS consisting of 1368.9 mM NaCl, 26.8 mM KCl, 63.9 mM <named-content content-type="chemical-compound">Na<sub>2</sub>PO<sub>4</sub></named-content>, 14.7 mM <named-content content-type="chemical-compound">KH<sub>2</sub>PO<sub>4</sub></named-content>, 9.0 mM <named-content content-type="chemical-compound">CaCl<sub>2</sub></named-content> and 4.9 mM <named-content content-type="chemical-compound">MgCl<sub>2</sub></named-content> (<xref ref-type="bibr" rid="ref-15">Dulbecco &amp; Vogt, 1954</xref>) instead of the standard laboratory reagents. The resulting Aβ peptide was assessed for concentration as described for the SAXS measurements. This process resulted in Aβ stock solutions of 180–250 µM. The concentrated peptide was diluted into the cell culture media A (F12K, 0.5% FCS, 100 ng/ml NGF, 100 U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate and 0.25 µg/ml amphotericin B) at no more than 1/10 so as not to affect the composition of the culture media. The vehicle was prepared in the culture media using the same dilution as the peptide. The media/vehicle was used to make subsequent dilutions of the peptide (10–20 µM). Cultures were also treated with the toxin control, staurosporine (1 µM).</p>
        <p>The cultures were incubated and assessed for viability after 48, 72 and 96 h using the CCK-8 reagent. Five minutes prior to the assay, a second toxin control (0.1% (v/v) Triton X-100) was added to the designated cells. The viability assay was done by aspirating the treatment media and replacing with cell culture media A containing 10% of the CCK-8 reagent (100 µl/well). The cultures were incubated for 2 h at 37°C and then measured for absorbance changes on the LabSystems Multiskan MS multiplate reader (ThermoFisher Scientific, Scoresby, Australia) using a 405 nm filter. Wells containing CCK-8 reagent and no cells were used to measure the background absorbance of the CCK-8/media and the values were subtracted from the test data. The absorbance readings for the untreated cells were normalised to 100% to adjust for variation between control values of individual experiments and the test data were expressed as a proportion of the untreated cells. The normalised data represent the mean and standard error of the mean (SEM) from 2–4 experiments. The normalised comparisons and the results were taken to be significant when the <italic>p</italic> value was below 0.05. The ANOVA and comparisons were done in a Microsoft<sup>®</sup> Office Excel spreadsheet.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Effect of solubilisation pretreatment method on Aβ amyloid formation</title>
        <p>The effect of HFIP treatment on amyloid formation by Aβ<sub>42</sub> peptides was investigated using a continuous ThT assay. ThT fluorescence was measured for solutions containing untreated, HFIP or <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> (<xref ref-type="fig" rid="fig-1">Fig. 1A</xref>) and resuspended using the standard NaOH protocol. The ThT fluorescence timecourse of untreated Aβ<sub>42</sub> was variable with an average <italic>t</italic>½ of approximately 14.9 ± 2.6 h (<xref ref-type="fig" rid="fig-1">Fig. 1A</xref>). Pretreatment with HFIP decreased the <italic>t</italic>½ by 6 h to approximately 9 ± 1.9 h, while <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreatment increased the average <italic>t</italic>½ to approximately 16.2 ± 1.3 h. In all cases we observe an initial increase in the ThT fluorescence intensity over the first hour, equivalent to approximately 10 arbitrary units, which is within the background of the timecourse assay and does not differ with Aβ<sub>42</sub> treatment. This increase could be attributed to a number of early events, ranging from temperature equilibration in the instrument through to the formation of cross-β sheets structures and early oligomers.</p>
        <fig id="fig-1">
          <object-id pub-id-type="doi">10.7717/peerj.73/fig-1</object-id>
          <label>Figure 1</label>
          <caption>
            <title>HFIP treatment significantly enhances the rate of fibril formation.</title>
            <p>(A) Analysis of HFIP, <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> effect on the aggregation kinetics of Aβ <sub>42</sub>by ThT fluorescence time course. Aβ<sub>42</sub> (5 µM) treated with HFIP (red circles, <italic>t</italic>½ ∼ 9 ± 1.9 h), <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> (blue circles, <italic>t</italic>½ ∼16.2 ± 1.3 h), or not treated at all (green circles, <italic>t</italic>½ ∼15 ± 2.6 h) prior to suspension into PBS.</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/73/fig-1.png"/>
        </fig>
      </sec>
      <sec>
        <title>Aggregation state of Aβ after dissolution.</title>
        <p>Due to the observed increase in the rate of fibril formation that occurs with HFIP pretreatment, we hypothesised that this solvent was not completely removing the oligomers, but was in fact allowing amyloid seeds to persist through the complete removal of HFIP and thereby accelerate aggregation and fibril formation. To investigate the starting aggregation state of Aβ<sub>42</sub> in solution we used dynamic light scattering, size exclusion chromatography and small angle X-ray scattering. DLS was used to investigate qualitative differences in the preparation techniques. DLS provides an approximate hydrodynamic radius based on the ability of a solution to scatter light and is sensitive to the presence of aggregates. While hydrodynamic radius is typically applied to spherical particles, in this case the approximate radius is sufficient to indicate a qualitative difference between the two treatments. The DLS measurements on average demonstrated that both the HFIP and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> treated Aβ<sub>42</sub> exist as a monomodal polydisperse solution (<xref ref-type="fig" rid="fig-2">Fig. 2A</xref>) however, the spread of data for both samples was quite wide, with the extremes of low and high distributions shown in the supplementary data (<xref ref-type="supplementary-material" rid="supp-1">Fig. S1</xref>). For the HFIP preparations we found a large degree of variability in the average distribution of five separate experiments with polydispersity factors ranging from 10%–52% and radii ranging from 3–100 nm (<xref ref-type="fig" rid="fig-2">Fig. 2A</xref>, red line). Given this variability, the most commonly observed average radius was 8 nm with approximately 50% polydispersity. In contrast, Aβ<sub>42</sub> pretreated with <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> was more consistent, with the average distribution of five separate experiments showing radii ranging from 1–10 nm and 30% polydispersity factors. The average radius of this sample was 3.5 nm with 30% polydispersity (<xref ref-type="fig" rid="fig-2">Fig. 2A</xref>).</p>
        <fig id="fig-2">
          <object-id pub-id-type="doi">10.7717/peerj.73/fig-2</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Pretreatment method determines the starting aggregation state of Aβ<sub>42</sub>.</title>
            <p>(A) Hydrodynamic radii were determined with dynamic light scattering measurements of Aβ<sub>42</sub> (100 µM) after treatment with HFIP (red line) or <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> (blue line). (B) Analysis of size distribution of HFIP (blue line) or <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> (red line) treated Aβ<sub>42</sub> (200 µM) solutions by SEC using Superdex S200 media.</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/73/fig-2.png"/>
        </fig>
        <p>Size exclusion analysis (<xref ref-type="fig" rid="fig-2">Fig. 2B</xref>) of HFIP and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> were consistent with the findings of the DLS experiments (<xref ref-type="fig" rid="fig-2">Fig. 2A</xref>). We observed that the treatment of Aβ<sub>42</sub> with HFIP had an elution profile that displayed a heterogeneous mix of species, ranging in elution volume from 8.5 ml (the void volume of the column) to approximately 20 ml (the total volume of the column) indicating a large range of species. Using the area under the peaks to estimate the percentage of protein present, the major peaks from the HFIP pretreated peptide occur at 8.5 ml (∼65% total protein) and 17 ml (∼20% total protein) indicating the presence of monomeric (∼5,000 Da) and large oligomeric species (MW greater than 80,000 Da). For <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> we observed a different bimodal distribution with a major (∼90% total protein) monomeric peak (MW ∼5,000 Da) eluting at 17 ml and a second minor (∼10% total protein) peak eluting at 12 ml, corresponding to a medium sized oligomeric species (MW ∼40,000–50,000 Da).</p>
      </sec>
      <sec>
        <title>Electron microscropy of the preparation techniques</title>
        <p>Aβ prepared for the ThT and SEC assays were analysed by TEM. Micrographs show that after 6 h at 37°C the Aβ<sub>42</sub> pretreated with HFIP has more protofibril/early fibril structures compared with the Aβ<sub>42</sub> pretreated with <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> (<xref ref-type="fig" rid="fig-3">Figs. 3A</xref> and <xref ref-type="fig" rid="fig-3">3B</xref>). The smaller structures of the latter are beyond the sensitivity of this technique (<xref ref-type="fig" rid="fig-3">Fig. 3B</xref>). In light of the differing buffer conditions used for DLS, the HFIP and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> prepared for DLS were also analysed by TEM (<xref ref-type="fig" rid="fig-3">Figs. 3C</xref> and <xref ref-type="fig" rid="fig-3">3D</xref>). The representative micrographs show that some short fibrils are present in the HFIP pretreated Aβ<sub>42</sub> solution (<xref ref-type="fig" rid="fig-3">Fig. 3C</xref>), whilst only small, unidentifiable structures are present in the <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated peptide solution (<xref ref-type="fig" rid="fig-3">Fig. 3D</xref>).</p>
        <fig id="fig-3">
          <object-id pub-id-type="doi">10.7717/peerj.73/fig-3</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Pretreatment method determines the starting aggregation state of Aβ<sub>42</sub> as determined by transmission electron microscopy.</title>
            <p>(A &amp; B) Micrographs from TEM analysis of HFIP (A) and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> (B) pretreated Aβ<sub>42</sub> as prepared for SEC and ThT, after 6 h of incubation. (C &amp; D) Further micrographs were acquired for samples prepared for DLS pretreated with HFIP (C) or <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> (D) Images captured 20 min post preparation. Scale bar = 200 nm.</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/73/fig-3.png"/>
        </fig>
      </sec>
      <sec>
        <title>Small angle X-ray scattering of HFIP or <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreatment</title>
        <p>In addition to the DLS and SEC measurements, we also investigated the initial aggregation state by SAXS measurements (<xref ref-type="fig" rid="fig-4">Fig. 4</xref>). A comparison of the SAXS data of the untreated (<xref ref-type="fig" rid="fig-4">Fig. 4A</xref>), HFIP treated (<xref ref-type="fig" rid="fig-4">Fig. 4B</xref>) and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> treated (<xref ref-type="fig" rid="fig-4">Fig. 4C</xref>) Aβ<sub>42</sub> highlights the different solution behaviour of these samples. The data indicates that all of the peptide solutions contained a polydisperse mix of aggregates, as the data in the low <italic>q</italic> region of the scattering curves displays a significant increase in intensity, highlighted in <xref ref-type="fig" rid="fig-4">Fig. 4D</xref>. This makes interpretation of the SAXS data in terms of shape or molecular weight difficult as the scattering from the aggregated material significantly distorts the analysis, however we can transform the data into a Kratky plot, which can give an indication of the folded/unfolded state of a protein (<xref ref-type="bibr" rid="ref-13">Doniach, 2001</xref>; <xref ref-type="bibr" rid="ref-37">Mertens &amp; Svergun, 2010</xref>), with folded proteins typically showing a prominent peak in the curve, while unfolded proteins show a continuous increase as <italic>s</italic> increases (for review of the basis of Kratky plots and on the analysis of SAXS data see (<xref ref-type="bibr" rid="ref-13">Doniach, 2001</xref>; <xref ref-type="bibr" rid="ref-46">Putnam et al., 2007</xref>)). The treated and untreated Aβ<sub>42</sub> show a qualitative difference in the potential degree of folded peptide represented by the scattering curves (<xref ref-type="fig" rid="fig-4">Fig. 4E</xref>). <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> shows a completely unfolded structure, whilst HFIP pretreated peptide appears to represent partially folded species (<xref ref-type="fig" rid="fig-4">Fig. 4E</xref>). The untreated peptide is intermediate in the degree of folded and unfolded peptide compared to HFIP and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> treatment.</p>
        <fig id="fig-4">
          <object-id pub-id-type="doi">10.7717/peerj.73/fig-4</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Small angle X-ray scattering analysis of the peptide treatments.</title>
            <p><named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> treated (A), HFIP treated (B) and untreated (C) Aβ<sub>42</sub> (220 µM) solutions. Panel D shows a ln/linear plot of the data for untreated (green), <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> (blue) and HFIP (red) treated Aβ over the range 0.001 &gt; <italic>q</italic> &gt; 0.1. For comparison the scattering curve of the structured and non-aggregated ribonuclease A (dotted line) is also plotted. Panel E shows the corresponding Kratky plots of the data (untreated: green line, HFIP treated: red line and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> treated: blue line).</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/73/fig-4.png"/>
        </fig>
        <fig id="fig-5">
          <object-id pub-id-type="doi">10.7717/peerj.73/fig-5</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Viability of PC12 cells assessed using the CCK-8 reagent.</title>
            <p>(A) PC12 cell viability after treatment with <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content>- and HFIP-pretreated Aβ<sub>42</sub> (10–20 µM) for 48 h. (B) PC12 cell viability after treatment with <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content>- and HFIP-pretreated Aβ<sub>42</sub> (10–20 µM) for 72 h. (C) PC12 cell viability after treatment with <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content>- and HFIP pretreated Aβ<sub>42</sub> (10–20 µM) for 96 h. The toxin controls, staurosporine (Stsp, 1 µM) and Triton X-100 (TX-100, 0.1%), reduce the cell viability by ≥ 99%. Data represent the mean±SEM of 2–4 experiments performed in triplicate (<italic>n</italic> = 6–12). *** <italic>p</italic> &lt; 0.001 for the Aβ<sub>42</sub> vs the vehicle treated cells. Grey bars = HFIP-pretreated Aβ<sub>42</sub>.</p>
          </caption>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/73/fig-5.png"/>
        </fig>
      </sec>
      <sec>
        <title>The effect of pretreatment on cellular toxicity</title>
        <p>Pretreatment of Aβ<sub>42</sub> has a large impact on the oligomerisation state of Aβ<sub>42</sub>, which is a key factor for toxicity <italic>in vitro</italic>. A CCK-8 toxicity assay was used to investigate how the Aβ<sub>42</sub> preparation method affects toxicity in PC12 cultures after 24–96 h. Cultures treated with both <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> and HFIP pretreated Aβ<sub>42</sub> (15–20 µM) were viable after 48 h (<xref ref-type="fig" rid="fig-5">Fig. 5A</xref>). Compared with vehicle treated cells, the PC12 cultures treated with <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> (15 and 20 µM) for 72 h showed a 15.7% (<italic>P</italic> &lt; 0.001) and 30.2% (<italic>P</italic> &lt; 0.001) decrease in viability, respectively (<xref ref-type="fig" rid="fig-5">Fig. 5B</xref>). In contrast, PC12 cultures treated with the HFIP pretreated Aβ<sub>42</sub> (10–20 µM) for 72 h did not show any loss of viability (<xref ref-type="fig" rid="fig-5">Fig. 5B</xref>). However, the PC12 cultures treated with the HFIP pretreated Aβ for 96 h, were 38.4% (<italic>P</italic> &lt; 0.001) less viable than vehicle treated cells but only at the highest concentration tested (20 µM, <xref ref-type="fig" rid="fig-5">Fig. 5C</xref>). After 96 h, the PC12 cultures treated with the <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ (15 and 20 µM) showed a 25.2% (<italic>P</italic> &lt; 0.001) and 42.1% (<italic>P</italic> &lt; 0.001) decrease in viability, respectively compared with vehicle treated cells (<xref ref-type="fig" rid="fig-5">Fig. 5C</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Fluorinated alcohols such as HFIP are widely used to break beta sheet structure and induce alpha helical conformations (<xref ref-type="bibr" rid="ref-21">Hirota, Mizuno &amp; Goto, 1997</xref>; <xref ref-type="bibr" rid="ref-6">Buck, 1998</xref>). These solvents have been used to inhibit processes involving beta sheet formation, mainly relating to amyloid aggregation (<xref ref-type="bibr" rid="ref-62">Zagorski &amp; Barrow, 1992</xref>; <xref ref-type="bibr" rid="ref-6">Buck, 1998</xref>; <xref ref-type="bibr" rid="ref-54">Stine et al., 2003</xref>). The exact protocol for the use of these solvents appears to vary dramatically. However, most protocols describe an initial incubation with HFIP followed by evaporation to dryness and suspension of the resulting film with some other solvent. Common examples of the secondary solvent include DMSO (<xref ref-type="bibr" rid="ref-54">Stine et al., 2003</xref>; <xref ref-type="bibr" rid="ref-25">Jiao et al., 2008</xref>), ammonium hydroxide (<xref ref-type="bibr" rid="ref-60">Yoda, Miura &amp; Takeuchi, 2008</xref>) or sodium hydroxide (<xref ref-type="bibr" rid="ref-8">Ciccotosto et al., 2011</xref>). In other cases the HFIP is not removed until after dissolution into aqueous buffer (for example <xref ref-type="bibr" rid="ref-27">Kayed et al., 2004</xref>), but this protocol is believed to be flawed as there is extensive evidence that low concentrations of HFIP are ineffective at dissociating oligomers (<xref ref-type="bibr" rid="ref-33">Lesne et al., 2006</xref>) and can actually enhance fibril formation (<xref ref-type="bibr" rid="ref-38">Nichols et al., 2005a</xref>; <xref ref-type="bibr" rid="ref-39">Nichols et al., 2005b</xref>; <xref ref-type="bibr" rid="ref-47">Rangachari et al., 2006</xref>).</p>
      <p>Despite the use of HFIP for the purposes of erasing conformational memory, there is little understanding of whether or not disaggregation is maintained during the removal of the HFIP from the Aβ sample and film formation. Previous work on Aβ peptide film formation from HFIP solutions suggests that producing a film of the peptide results in accumulation of a variety of aggregated structures (<xref ref-type="bibr" rid="ref-40">Pachahara et al., 2012</xref>). Moreover, it has been suggested that HFIP disaggregation of Aβ peptides is also inconsistent, with a DLS study showing that the peptide can self-associate within the HFIP solution (<xref ref-type="bibr" rid="ref-18">Fulop et al., 2006</xref>).</p>
      <p>In this study, we have determined that HFIP pretreatment and film formation has adverse effects on the subsequent aggregation of Aβ<sub>42</sub> in an aqueous buffer system. Our study shows that HFIP treatment followed by sodium hydroxide resuspension adversely affects the starting aggregation state of the resuspended peptide, inducing a large proportion of small aggregates, otherwise unidentifiable by TEM but quantifiable by SEC, DLS and SAXS measurements. Interestingly, the starting aggregation state was consistently worse with HFIP pretreated Aβ<sub>42</sub> independent of the secondary buffer used for biophysical analysis including both Tris.HCl pH 8.0 and PBS pH 7.4, indicating that buffer composition and pH 7.4–8.0 had little impact on the initial aggregation state. The large proportion of aggregate in the HFIP pre-treated Aβ<sub>42</sub> increases the kinetics of amyloid fibril formation, presumably due to increased number of nucli for fibril formation at <italic>t</italic> = 0. Similar to the observation of Stine et al.(<xref ref-type="bibr" rid="ref-54">Stine et al., 2003</xref>), the peptide films produced from HFIP treatment were difficult to resuspend consistently, leading to large variations in the concentration of the stock solution of peptide (data not shown). In contrast, treatment of Aβ with <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> results in fluffy white powder that yields consistent concentrations of Aβ stock solutions (CV ∼ 10–15% based on the starting weight of the peptide).</p>
      <p>Strong alkalis such as ammonium hydroxide, which do not approach the pI of Aβ (pI ∼ 5) upon neutralisation, have been widely used as initial solubilisation agents for synthetic and <italic>ex vivo</italic> peptides. Solubilisation of amyloid by alkali has long been known to be effective, with the earliest report of its use in the isolation of amyloid from tissue samples occurring in 1898 (<xref ref-type="bibr" rid="ref-30">Krakow, 1898</xref>), followed by several other reports of the use of barium hydroxide, ammonium hydroxide, sodium hydroxide, calcium hydroxide, alkaline borate and alkaline buffered phosphate for solubilisation and analysis of amyloid deposits in tissue samples (<xref ref-type="bibr" rid="ref-52">Shirahama &amp; Cohen, 1967</xref>; <xref ref-type="bibr" rid="ref-45">Pras et al., 1969</xref>; <xref ref-type="bibr" rid="ref-42">Perry et al., 1981</xref>; <xref ref-type="bibr" rid="ref-14">Dubois et al., 1999</xref>). In particular, sodium and ammonium hydroxides were observed to be the most effective in both preventing aggregation and disaggregating fibrillar structures (<xref ref-type="bibr" rid="ref-52">Shirahama &amp; Cohen, 1967</xref>). More recently, ammonium hydroxide has been found to be of use in HPLC analysis of synthetic Aβ peptides, where buffering the samples with 0.2% ammonium hydroxide results in improved peak shape, retention and sample recovery (<xref ref-type="bibr" rid="ref-32">Lame, Chambers &amp; Blatnik, 2011</xref>). Furthermore, ammonium hydroxide pretreatment has been shown previously to be of use in producing homogenous solutions of Aβ consisting primarily of low molecular weight species by Fezouiet al. (<xref ref-type="bibr" rid="ref-16">Fezoui et al., 2000</xref>; <xref ref-type="bibr" rid="ref-17">Fezoui &amp; Teplow, 2002</xref>; <xref ref-type="bibr" rid="ref-55">Teplow, 2006</xref>). As initial pretreatment buffers, the aforementioned studies used 2 mM NaOH for Aβ<sub>40</sub> or 10 mM <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content>/6 M guanidine HCl for both Aβ<sub>40</sub> and Aβ<sub>42</sub> and the analytical techniques included fourier transform infrared spectroscopy, circular dichroism, atomic force microscopy, congo red binding, SEC, electron microscopy and neurotoxicity. Hence, our study is the first to directly compare HFIP to <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> using analytical techniques including ThT binding, DLS, SEC, SAXS, electron microscopy and neuronal cell viability. We found that ammonium hydroxide pretreatment and lyophilisation typically resulted in an Aβ<sub>42</sub> peptide residue that resembled “fairy floss”. This lyophilised peptide resuspended extremely well when subjected to the sodium hydroxide resuspension protocol described in the methods section and the SAXS, DLS, SEC and electron microscopy analyses all indicated that the resulting solution contained a much lower proportion of structured aggregated material. The ThT analysis of the rate of aggregation indicated that the <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> gives consistent amyloid fibril formation kinetics, which were marginally slower then those of the untreated Aβ<sub>42</sub> peptide, suggesting that this protocol does not increase the amyloid forming potential of the starting solution. This treatment protocol also decreased the variability in aggregation rate observed with the untreated peptide, with independent experiments producing differences in <italic>t</italic>½ of 5.2 h and 2.6 h for untreated and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> treated peptide, respectively. In contrast to DMSO solvent, <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> has the advantage of being more compatible with analytical methods because low amounts of DMSO can interfere with UV absorbance measurements. In addition 0.5–1% DMSO is toxic to hippocampal neuronal cultures (<xref ref-type="bibr" rid="ref-20">Hanslick et al., 2009</xref>) and has some potentially adverse effects on Aβ including denaturation (<xref ref-type="bibr" rid="ref-24">Jackson &amp; Mantsch, 1991</xref>), inhibition of Aβ aggregation (<xref ref-type="bibr" rid="ref-51">Shen &amp; Murphy, 1995</xref>) and inhibition of Aβ oxidative processes (<xref ref-type="bibr" rid="ref-9">Davis et al., 2011</xref>).</p>
      <p>As observed by DLS, SEC and SAXS, the composition of the soluble material is different between the two pre-treatments (HFIP Aβ<sub>42</sub> has higher molecular weight aggregates compared with the <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> material). The HFIP pretreated Aβ<sub>42</sub> had a faster propensity to aggregate in the ThT assay (<xref ref-type="fig" rid="fig-1">Fig. 1</xref>). The HFIP pretreated Aβ<sub>42</sub> was less toxic to PC12 cultures compared with <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> at 72 and 96 h post-treatment (<xref ref-type="fig" rid="fig-5">Fig. 5</xref>). These data suggest that the HFIP and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> Aβ<sub>42</sub> may interact with the cell differently including differences in peptide affinity for the cell membrane, thereby affecting the toxicity. These data are consistent with the <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> material transitioning through a toxic intermediate, while the HFIP treated peptide appears to require extra time to develop toxicity. We hypothesise that the reduced toxicity of HFIP treated peptide is due to a decreased availability of effective (toxic) Aβ<sub>42</sub> because it is terminally trapped upon dissolution in a variety of non-toxic structures. Additionally, the observed delay in toxicity with HFIP pretreated Aβ<sub>42</sub> may be due to a requirement for disaggregation of already formed non-toxic aggregates to toxic oligomers.</p>
      <p>The aggregation of the HFIP and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ<sub>42</sub> peptide in the ThT and cell assays may be different due to the inherent complexity of cells and the effects of biological membranes, chaperones, metals and other proteins on aggregation kinetics of Aβ. There is strong evidence to support that once the Aβ<sub>42</sub> peptide is added to cell cultures, it binds to the cell membrane and is internalised (<xref ref-type="bibr" rid="ref-11">Decker et al., 2010</xref>; <xref ref-type="bibr" rid="ref-26">Johnson et al., 2011</xref>). Cell bound Aβ structures range from monomers to hexamers and greater (<xref ref-type="bibr" rid="ref-26">Johnson et al., 2011</xref>). Whilst the Aβ structure(s) which cause toxicity are unknown, there is a sequelae of pathological events including binding of Aβ to synapse receptors (NMDA - (<xref ref-type="bibr" rid="ref-10">De Felice et al., 2007</xref>), α7 Nicotinic acetylcholine receptor – (<xref ref-type="bibr" rid="ref-57">Wang et al., 2000</xref>)), an increase in calcium flux (<xref ref-type="bibr" rid="ref-12">Demuro et al., 2005</xref>; <xref ref-type="bibr" rid="ref-53">Simakova &amp; Arispe, 2007</xref>), depolarisation of cell membrane (<xref ref-type="bibr" rid="ref-4">Blanchard, Thomas &amp; Ingram, 2002</xref>), increased reactive oxygen species (<xref ref-type="bibr" rid="ref-41">Parks et al., 2001</xref>) and impaired axonal transport (<xref ref-type="bibr" rid="ref-58">Wang et al., 2010</xref>) which leads to cell toxicity. Thus, data interpretation across the <italic>in vitro</italic> cell-free and cell assays should be made with caution.</p>
      <p>Using the preparation of Aβ<sub>42</sub> described in the present study, toxicity is observed at 72–96 h post-treatment with no toxicity at an earlier time point (48 h). The 72–96 h time frame for toxicity is consistent with that reported by others (<xref ref-type="bibr" rid="ref-16">Fezoui et al., 2000</xref>; <xref ref-type="bibr" rid="ref-2">Barnham et al., 2003</xref>; <xref ref-type="bibr" rid="ref-23">Hung et al., 2008</xref>; <xref ref-type="bibr" rid="ref-8">Ciccotosto et al., 2011</xref>; <xref ref-type="bibr" rid="ref-3">Benilova, Karran &amp; De Strooper, 2012</xref>). Studies that show Aβ toxicity in neuronal cultures after 1–24 h could reflect peptide with residual HFIP which is toxic (at concentrations &gt;40 mM) to SH-SY5Y cells within the 24 h time (<xref ref-type="bibr" rid="ref-7">Capone et al., 2009</xref>). We hypothesize that the greater toxicity of <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> pretreated Aβ at lower concentrations and earlier time points is due to a greater concentration of effective (toxic) Aβ. After HFIP treatment ∼60% of the Aβ were trapped as high molecular weight oligomers; provided this is also the case in cell experiments, these high molecular weight oligomers were not immediately toxic to PC12 cultures and thus additional time may be required for the high molecular weight oligomers to transition to the toxic intermediate. Alternatively, after HFIP treatment ∼40% of the total Aβ concentration were low molecular weight oligomers which may be too dilute to induce a toxic response in PC12 cultures. In general, these data indicate that the starting oligomeric status of Aβ is an important factor for the observed toxicity.</p>
      <p>In conclusion, we find that the use of HFIP alone is inappropriate for the stated purpose of producing a seed free solution of Aβ. We also find that ammonium hydroxide is a much more effective pretreatment which produces a mostly seed free solution of Aβ upon resuspension with a sodium hydroxide protocol. We suggest that this approach is a much more appropriate treatment for biophysical and cell biology experiments of Aβ.</p>
    </sec>
    <sec sec-type="supplementary-material" id="supplemental-information">
      <title>Supplemental Information</title>
      <supplementary-material id="supp-1" mimetype="image" mime-subtype="jpeg" xlink:href="https://peerj.com/articles/73/FigS1.jpg">
        <object-id pub-id-type="doi">10.7717/peerj.73/supp-1</object-id>
        <label>Figure S1</label>
        <caption>
          <title>Examples of the spread of data acquired by DLS</title>
          <p>Plotted are the two extremes of the data (smallest radii observed blue, largest distribution, orange) and the most commonly observed distribution for both HFIP (A) and <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> (B) treated Aβ (black). These datasets indicate that the HFIP is consistently distributed over a larger range of radii then the <named-content content-type="chemical-compound">NH<sub>4</sub>OH</named-content> treated peptide.</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>SAXS measurements were acquired at the SAXS/WAXS beamline of the Australian Synchrotron (Clayton, Victoria, Australia).</p>
    </ack>
    <sec sec-type="additional-information">
      <title>Additional Information and Declarations</title>
      <fn-group content-type="competing-interests">
        <title>Competing Interests</title>
        <fn id="conflict-1" fn-type="con">
          <p>Colin L. Masters is an Academic Editor for PeerJ. Nigel Kirby and Haydyn D.T. Mertens are employees of SAXS/WAXS Beamline, Australian Synchrotron Company, Ltd. No other competing interests to declare.</p>
        </fn>
      </fn-group>
      <fn-group content-type="author-contributions">
        <title>Author Contributions</title>
        <fn id="contribution-1" fn-type="con">
          <p><xref ref-type="contrib" rid="author-1">Timothy M. Ryan</xref>, <xref ref-type="contrib" rid="author-2">Joanne Caine</xref>, <xref ref-type="contrib" rid="author-5">Julie Nigro</xref> and <xref ref-type="contrib" rid="author-11">Blaine R. Roberts</xref> conceived and designed the experiments, performed the experiments, analyzed the data, contributed reagents/materials/analysis tools, wrote the paper.</p>
        </fn>
        <fn id="contribution-2" fn-type="con">
          <p><xref ref-type="contrib" rid="author-3">Haydyn D.T. Mertens</xref> performed the experiments, analyzed the data, contributed reagents/materials/analysis tools.</p>
        </fn>
        <fn id="contribution-3" fn-type="con">
          <p><xref ref-type="contrib" rid="author-4">Nigel Kirby</xref> and <xref ref-type="contrib" rid="author-10">Colin L. Masters</xref> contributed reagents/materials/analysis tools.</p>
        </fn>
        <fn id="contribution-4" fn-type="con">
          <p><xref ref-type="contrib" rid="author-6">Kerry Breheney</xref> and <xref ref-type="contrib" rid="author-7">Lynne J. Waddington</xref> performed the experiments, contributed reagents/materials/analysis tools.</p>
        </fn>
        <fn id="contribution-5" fn-type="con">
          <p><xref ref-type="contrib" rid="author-8">Victor A. Streltsov</xref> analyzed the data, contributed reagents/materials/analysis tools.</p>
        </fn>
        <fn id="contribution-6" fn-type="con">
          <p><xref ref-type="contrib" rid="author-9">Cyril Curtain</xref> conceived and designed the experiments, analyzed the data, contributed reagents/materials/analysis tools.</p>
        </fn>
      </fn-group>
    </sec>
    <ref-list content-type="authoryear">
      <title>References</title>
      <ref id="ref-1">
        <label>Ahmed et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahmed</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aucoin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ahuja</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aimoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Elliott</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Van Nostrand</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>SO</given-names>
            </name>
          </person-group>
          <article-title>Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils</article-title>
          <source>Nature Structural &amp; Molecular Biology</source>
          <issue>5</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>17</volume>
          <fpage>561</fpage>
          <lpage>567</lpage>
          <pub-id pub-id-type="doi">10.1038/nsmb.1799</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-2">
        <label>Barnham et al. (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnham</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Ciccotosto</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Tickler</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Carrington</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tew</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kocak</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Volitakis</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Separovic</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Barrow</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Wade</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Masters</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Cherny</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Curtain</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Bush</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Cappai</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Neurotoxic, redox-competent Alzheimer’s beta-amyloid is released from lipid membrane by methionine oxidation</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>44</issue>
          <year iso-8601-date="2003">2003</year>
          <volume>278</volume>
          <fpage>42959</fpage>
          <lpage>42965</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M305494200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-3">
        <label>Benilova, Karran &amp; De Strooper (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benilova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Karran</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>De Strooper</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>The toxic Abeta oligomer and Alzheimer’s disease: an emperor in need of clothes</article-title>
          <source>Nature Neuroscience</source>
          <issue>3</issue>
          <year iso-8601-date="2012">2012</year>
          <volume>15</volume>
          <fpage>349</fpage>
          <lpage>357</lpage>
          <pub-id pub-id-type="doi">10.1038/nn.3028</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-4">
        <label>Blanchard, Thomas &amp; Ingram (2002)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blanchard</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Ingram</surname>
              <given-names>VM</given-names>
            </name>
          </person-group>
          <article-title>Mechanism of membrane depolarization caused by the Alzheimer Abeta1-42 peptide</article-title>
          <source>Biochemical and Biophysical Research Communications</source>
          <issue>4</issue>
          <year iso-8601-date="2002">2002</year>
          <volume>293</volume>
          <fpage>1197</fpage>
          <lpage>1203</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-291X(02)00346-7</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-5">
        <label>Broersen et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Broersen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jonckheere</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Rozenski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vandersteen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pauwels</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pastore</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rousseau</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Schymkowitz</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A standardized and biocompatible preparation of aggregate-free amyloid beta peptide for biophysical and biological studies of Alzheimer’s disease</article-title>
          <source>Protein Engineering Design and Selection</source>
          <issue>9</issue>
          <year iso-8601-date="2011">2011</year>
          <volume>24</volume>
          <fpage>743</fpage>
          <lpage>750</lpage>
          <pub-id pub-id-type="doi">10.1093/protein/gzr020</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-6">
        <label>Buck (1998)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buck</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins</article-title>
          <source>Quarterly Reviews of Biophysics</source>
          <issue>3</issue>
          <year iso-8601-date="1998">1998</year>
          <volume>31</volume>
          <fpage>297</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="doi">10.1017/S003358359800345X</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-7">
        <label>Capone et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Capone</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Quiroz</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Prangkio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Saluja</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Bautista</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy</article-title>
          <source>Neurotoxicity Research</source>
          <issue>1</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>16</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1007/s12640-009-9033-1</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-8">
        <label>Ciccotosto et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciccotosto</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Tew</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Drew</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Johanssen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lal</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Curtain</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Wade</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Separovic</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Masters</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Barnham</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Cappai</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Stereospecific interactions are necessary for Alzheimer disease amyloid-beta toxicity</article-title>
          <source>Neurobiology of Aging</source>
          <issue>2</issue>
          <year iso-8601-date="2011">2011</year>
          <volume>32</volume>
          <fpage>235</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.02.018</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-9">
        <label>Davis et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davis</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Marsden</surname>
              <given-names>IT</given-names>
            </name>
            <name>
              <surname>Maloney</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Minamide</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Podlisny</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Selkoe</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Bamburg</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation</article-title>
          <source>Molecular Neurodegeneration</source>
          <year iso-8601-date="2011">2011</year>
          <volume>6</volume>
          <fpage>1</fpage>
          <lpage>16</lpage>
          <pub-id pub-id-type="doi">10.1186/1750-1326-6-10</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-10">
        <label>De Felice et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Felice</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Velasco</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Viola</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>15</issue>
          <year iso-8601-date="2007">2007</year>
          <volume>282</volume>
          <fpage>11590</fpage>
          <lpage>11601</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M607483200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-11">
        <label>Decker et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Decker</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jurgensen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Adrover</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Brito-Moreira</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bomfim</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>De Felice</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Jerusalinsky</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>ST</given-names>
            </name>
          </person-group>
          <article-title>N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer’s toxic amyloid-beta peptide oligomers</article-title>
          <source>Journal of Neurochemistry</source>
          <issue>6</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>115</volume>
          <fpage>1520</fpage>
          <lpage>1529</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.07058.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-12">
        <label>Demuro et al. (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demuro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mina</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kayed</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Milton</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Glabe</surname>
              <given-names>CG</given-names>
            </name>
          </person-group>
          <article-title>Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>17</issue>
          <year iso-8601-date="2005">2005</year>
          <volume>280</volume>
          <fpage>17294</fpage>
          <lpage>17300</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M500997200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-13">
        <label>Doniach (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Doniach</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Changes in biomolecular conformation seen by small angle X-ray scattering</article-title>
          <source>Chemical Reviews</source>
          <issue>6</issue>
          <year iso-8601-date="2001">2001</year>
          <volume>101</volume>
          <fpage>1763</fpage>
          <lpage>1778</lpage>
          <pub-id pub-id-type="doi">10.1021/cr990071k</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-14">
        <label>Dubois et al. (1999)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dubois</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ismail</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Ali-Khan</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Fourier transform infrared spectroscopic investigation of temperature- and pressure-induced disaggregation of amyloid A</article-title>
          <source>Scandinavian Journal of Immunology</source>
          <issue>4</issue>
          <year iso-8601-date="1999">1999</year>
          <volume>49</volume>
          <fpage>376</fpage>
          <lpage>380</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1365-3083.1999.00508.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-15">
        <label>Dulbecco &amp; Vogt (1954)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dulbecco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Vogt</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Plaque formation and isolation of pure lines with poliomyelitis viruses</article-title>
          <source>Journal of Experimental Medicine</source>
          <issue>2</issue>
          <year iso-8601-date="1954">1954</year>
          <volume>99</volume>
          <fpage>167</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.99.2.167</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-16">
        <label>Fezoui et al. (2000)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fezoui</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hartley</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Khurana</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Condron</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Selkoe</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Lansbury</surname>
              <given-names>PT</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Teplow</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments</article-title>
          <source>Amyloid</source>
          <issue>3</issue>
          <year iso-8601-date="2000">2000</year>
          <volume>7</volume>
          <fpage>166</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="doi">10.3109/13506120009146831</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-17">
        <label>Fezoui &amp; Teplow (2002)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fezoui</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Teplow</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>40</issue>
          <year iso-8601-date="2002">2002</year>
          <volume>277</volume>
          <fpage>36948</fpage>
          <lpage>36954</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M204168200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-18">
        <label>Fulop et al. (2006)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fulop</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zarandi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Soos</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Penke</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Self-assembly of Alzheimer’s disease-related amyloid peptides into highly ordered nanostructures</article-title>
          <source>Nanopages</source>
          <year iso-8601-date="2006">2006</year>
          <volume>1</volume>
          <fpage>69</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1556/NANO.1.2006.1.3</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-19">
        <label>Glenner &amp; Wong (1984)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glenner</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein</article-title>
          <source>Biochemical and Biophysical Research Communications</source>
          <issue>3</issue>
          <year iso-8601-date="1984">1984</year>
          <volume>120</volume>
          <fpage>885</fpage>
          <lpage>890</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-291X(84)80190-4</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-20">
        <label>Hanslick et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanslick</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Noguchi</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Olney</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Zorumski</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Mennerick</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Farber</surname>
              <given-names>NB</given-names>
            </name>
          </person-group>
          <article-title>Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system</article-title>
          <source>Neurobiology of Disease</source>
          <issue>1</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>34</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nbd.2008.11.006</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-21">
        <label>Hirota, Mizuno &amp; Goto (1997)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirota</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mizuno</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Cooperative alpha-helix formation of beta-lactoglobulin and melittin induced by hexafluoroisopropanol</article-title>
          <source>Protein Science</source>
          <issue>2</issue>
          <year iso-8601-date="1997">1997</year>
          <volume>6</volume>
          <fpage>416</fpage>
          <lpage>421</lpage>
          <pub-id pub-id-type="doi">10.1002/pro.5560060218</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-22">
        <label>Huang et al. (2004)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Atwood</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Moir</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Hartshorn</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Tanzi</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Bush</surname>
              <given-names>AI</given-names>
            </name>
          </person-group>
          <article-title>Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Abeta peptides</article-title>
          <source>Journal of Biological Inorganic Chemistry</source>
          <issue>8</issue>
          <year iso-8601-date="2004">2004</year>
          <volume>9</volume>
          <fpage>954</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="doi">10.1007/s00775-004-0602-8</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-23">
        <label>Hung et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hung</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Ciccotosto</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Giannakis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tew</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Masters</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Cappai</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wade</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Barnham</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity</article-title>
          <source>Journal of Neuroscience</source>
          <issue>46</issue>
          <year iso-8601-date="2008">2008</year>
          <volume>28</volume>
          <fpage>11950</fpage>
          <lpage>11958</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3916-08.2008</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-24">
        <label>Jackson &amp; Mantsch (1991)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mantsch</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <source>Biochimica et Biophysica Acta</source>
          <year iso-8601-date="1991">1991</year>
          <volume>1078</volume>
          <fpage>231</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="doi">10.1016/0167-4838(91)90563-F</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-25">
        <label>Jiao et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xue</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jing</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Triptolide inhibits amyloid-beta1-42-induced TNF-alpha and IL-1beta production in cultured rat microglia</article-title>
          <source>Journal of Neuroimmunology</source>
          <issue>1–2</issue>
          <year iso-8601-date="2008">2008</year>
          <volume>205</volume>
          <fpage>32</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.08.006</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-26">
        <label>Johnson et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Schauerte</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Wisser</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Gafni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Steel</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Direct observation of single amyloid-beta(1-40) oligomers on live cells: binding and growth at physiological concentrations</article-title>
          <source>PLoS ONE</source>
          <issue>8</issue>
          <year iso-8601-date="2011">2011</year>
          <volume>6</volume>
          <elocation-id>e23970</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0023970</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-27">
        <label>Kayed et al. (2004)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kayed</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sokolov</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Edmonds</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>McIntire</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Milton</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Glabe</surname>
              <given-names>CG</given-names>
            </name>
          </person-group>
          <article-title>Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>45</issue>
          <year iso-8601-date="2004">2004</year>
          <volume>279</volume>
          <fpage>46363</fpage>
          <lpage>46366</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.C400260200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-28">
        <label>Kirkitadze, Bitan &amp; Teplow (2002)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kirkitadze</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Bitan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Teplow</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Paradigm shifts in Alzheimer’s disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies</article-title>
          <source>Journal of Neuroscience Research</source>
          <issue>5</issue>
          <year iso-8601-date="2002">2002</year>
          <volume>69</volume>
          <fpage>567</fpage>
          <lpage>577</lpage>
          <pub-id pub-id-type="doi">10.1002/jnr.10328</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-29">
        <label>Konarev et al. (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Konarev</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Volkov</surname>
              <given-names>VV</given-names>
            </name>
            <name>
              <surname>Sokolova</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>MHJ</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>DI</given-names>
            </name>
          </person-group>
          <article-title>PRIMUS: a Windows PC-based system for small-angle scattering data analysis</article-title>
          <source>Journal of Applied Crystallography</source>
          <year iso-8601-date="2003">2003</year>
          <volume>36</volume>
          <fpage>1277</fpage>
          <lpage>1282</lpage>
          <pub-id pub-id-type="doi">10.1107/S0021889803012779</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-30">
        <label>Krakow (1898)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>NP</given-names>
            </name>
          </person-group>
          <article-title>Beitdige zur chemie der amyloidenartung</article-title>
          <source>Archive fur Experimentelle Pathologie und Pharmokologie</source>
          <year iso-8601-date="1898">1898</year>
          <volume>40</volume>
          <fpage>195</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01929781</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-31">
        <label>Lambert et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lambert</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Viola</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Chromy</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Venton</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Krafft</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Finch</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies</article-title>
          <source>Journal of Neurochemistry</source>
          <issue>3</issue>
          <year iso-8601-date="2001">2001</year>
          <volume>79</volume>
          <fpage>595</fpage>
          <lpage>605</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00592.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-32">
        <label>Lame, Chambers &amp; Blatnik (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lame</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Chambers</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Blatnik</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Quantitation of amyloid beta peptides Abeta(1-38), Abeta(1-40), and Abeta(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry</article-title>
          <source>Analytical Biochemistry</source>
          <issue>2</issue>
          <year iso-8601-date="2011">2011</year>
          <volume>419</volume>
          <fpage>133</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ab.2011.08.010</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-33">
        <label>Lesne et al. (2006)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lesne</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Kotilinek</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kayed</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Glabe</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gallagher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ashe</surname>
              <given-names>KH</given-names>
            </name>
          </person-group>
          <article-title>A specific amyloid-beta protein assembly in the brain impairs memory</article-title>
          <source>Nature</source>
          <issue>7082</issue>
          <year iso-8601-date="2006">2006</year>
          <volume>440</volume>
          <fpage>352</fpage>
          <lpage>357</lpage>
          <pub-id pub-id-type="doi">10.1038/nature04533</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-34">
        <label>Masters et al. (1985)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masters</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Simms</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Weinman</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Multhaup</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Beyreuther</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Amyloid plaque core protein in Alzheimer disease and Down syndrome</article-title>
          <source>Proceedings of the National Academy of Sciences of the United States of America</source>
          <issue>12</issue>
          <year iso-8601-date="1985">1985</year>
          <volume>82</volume>
          <fpage>4245</fpage>
          <lpage>4249</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.82.12.4245</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-35">
        <label>McColl et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McColl</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Gunn</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Tew</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Masters</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Barnham</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Cherny</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Bush</surname>
              <given-names>AI</given-names>
            </name>
          </person-group>
          <article-title>The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>34</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>284</volume>
          <fpage>22697</fpage>
          <lpage>22702</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.C109.028514</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-36">
        <label>McLean et al. (1999)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McLean</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Cherny</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Fraser</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Fuller</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Beyreuther</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bush</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Masters</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease</article-title>
          <source>Annals of Neurology</source>
          <issue>6</issue>
          <year iso-8601-date="1999">1999</year>
          <volume>46</volume>
          <fpage>860</fpage>
          <lpage>866</lpage>
          <pub-id pub-id-type="doi">10.1002/1531-8249(199912)46:6&lt;860::AID-ANA8&gt;3.0.CO;2-M</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-37">
        <label>Mertens &amp; Svergun (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mertens</surname>
              <given-names>HD</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>DI</given-names>
            </name>
          </person-group>
          <article-title>Structural characterization of proteins and complexes using small-angle X-ray solution scattering</article-title>
          <source>Journal of Structural Biology</source>
          <issue>1</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>172</volume>
          <fpage>128</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jsb.2010.06.012</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-38">
        <label>Nichols et al. (2005a)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nichols</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Cratic-McDaniel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hoh</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Rosenberry</surname>
              <given-names>TL</given-names>
            </name>
          </person-group>
          <article-title>Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>4</issue>
          <year iso-8601-date="2005">2005a</year>
          <volume>280</volume>
          <fpage>2471</fpage>
          <lpage>2480</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M410553200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-39">
        <label>Nichols et al. (2005b)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nichols</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Hoh</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Rosenberry</surname>
              <given-names>TL</given-names>
            </name>
          </person-group>
          <article-title>Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers</article-title>
          <source>Microscopy Research and Technique</source>
          <issue>3–4</issue>
          <year iso-8601-date="2005">2005b</year>
          <volume>67</volume>
          <fpage>164</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="doi">10.1002/jemt.20189</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-40">
        <label>Pachahara et al. (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pachahara</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Chaudhary</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Subbalakshmi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nagaraj</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Hexafluoroisopropanol induces self-assembly of beta-amyloid peptides into highly ordered nanostructures</article-title>
          <source>Journal of Peptide Science</source>
          <issue>4</issue>
          <year iso-8601-date="2012">2012</year>
          <volume>18</volume>
          <fpage>233</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="doi">10.1002/psc.2391</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-41">
        <label>Parks et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parks</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Trimmer</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>JP</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>WD</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro</article-title>
          <source>Journal of Neurochemistry</source>
          <issue>4</issue>
          <year iso-8601-date="2001">2001</year>
          <volume>76</volume>
          <fpage>1050</fpage>
          <lpage>1056</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00112.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-42">
        <label>Perry et al. (1981)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perry</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Oakley</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Candy</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Properties and possible significance of substance P and insulin fibrils</article-title>
          <source>Neuroscience Letters</source>
          <issue>3</issue>
          <year iso-8601-date="1981">1981</year>
          <volume>25</volume>
          <fpage>321</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="doi">10.1016/0304-3940(81)90412-2</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-43">
        <label>Petoukhov et al. (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petoukhov</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Franke</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shkumatov</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Tria</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kikhney</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Gajda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gorba</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>HDT</given-names>
            </name>
            <name>
              <surname>Konarev</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>DI</given-names>
            </name>
          </person-group>
          <article-title>New developments in the ATSAS program package for small-angle scattering data analysis</article-title>
          <source>Journal of Applied Crystallography</source>
          <year iso-8601-date="2012">2012</year>
          <volume>45</volume>
          <fpage>342</fpage>
          <lpage>350</lpage>
          <pub-id pub-id-type="doi">10.1107/S0021889812007662</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-44">
        <label>Petoukhov et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petoukhov</surname>
              <given-names>MV</given-names>
            </name>
            <name>
              <surname>Konarev</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Kikhney</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Svergun</surname>
              <given-names>DI</given-names>
            </name>
          </person-group>
          <article-title>ATSAS 2.1 - towards automated and web-supported small-angle scattering data analysis</article-title>
          <source>Journal of Applied Crystallography</source>
          <year iso-8601-date="2007">2007</year>
          <volume>40</volume>
          <fpage>S223</fpage>
          <lpage>S228</lpage>
          <pub-id pub-id-type="doi">10.1107/S0021889807002853</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-45">
        <label>Pras et al. (1969)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pras</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zucker-Franklin</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rimon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Franklin</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
          <article-title>Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. Comparative analyses of nine amyloid preparations</article-title>
          <source>Journal of Experimental Medicine</source>
          <issue>4</issue>
          <year iso-8601-date="1969">1969</year>
          <volume>130</volume>
          <fpage>777</fpage>
          <lpage>796</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.130.4.777</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-46">
        <label>Putnam et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Putnam</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Hammel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hura</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Tainer</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution</article-title>
          <source>Quarterly Reviews of Biophysics</source>
          <issue>3</issue>
          <year iso-8601-date="2007">2007</year>
          <volume>40</volume>
          <fpage>191</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="doi">10.1017/S0033583507004635</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-47">
        <label>Rangachari et al. (2006)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rangachari</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Rosenberry</surname>
              <given-names>TL</given-names>
            </name>
          </person-group>
          <article-title>Secondary structure and interfacial aggregation of amyloid-beta(1-40) on sodium dodecyl sulfate micelles</article-title>
          <source>Biochemistry</source>
          <issue>28</issue>
          <year iso-8601-date="2006">2006</year>
          <volume>45</volume>
          <fpage>8639</fpage>
          <lpage>8648</lpage>
          <pub-id pub-id-type="doi">10.1021/bi060323t</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-48">
        <label>Ryan et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryan</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Narrow</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Federoff</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Bowers</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies</article-title>
          <source>Journal of Neuroscience Methods</source>
          <issue>2</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>190</volume>
          <fpage>171</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jneumeth.2010.05.001</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-49">
        <label>Ryan et al. (2012)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryan</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Friedhuber</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lind</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Howlett</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Masters</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
          <article-title>Small amphipathic molecules modulate secondary structure and amyloid fibril-forming kinetics of alzheimer disease peptide Abeta1-42</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>20</issue>
          <year iso-8601-date="2012">2012</year>
          <volume>287</volume>
          <fpage>16947</fpage>
          <lpage>16954</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M111.321778</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-50">
        <label>Sahoo et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sahoo</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nag</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sengupta</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Maiti</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>On the stability of the soluble amyloid aggregates</article-title>
          <source>Biophysical Journal</source>
          <issue>5</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>97</volume>
          <fpage>1454</fpage>
          <lpage>1460</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bpj.2009.05.055</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-51">
        <label>Shen &amp; Murphy (1995)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Solvent effects on self-assembly of beta-amyloid peptide</article-title>
          <source>Biophysical Journal</source>
          <issue>2</issue>
          <year iso-8601-date="1995">1995</year>
          <volume>69</volume>
          <fpage>640</fpage>
          <lpage>651</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-3495(95)79940-4</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-52">
        <label>Shirahama &amp; Cohen (1967)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shirahama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Reconstitution of amyloid fibrils from alkaline extracts</article-title>
          <source>Journal of Cell Biology</source>
          <issue>2</issue>
          <year iso-8601-date="1967">1967</year>
          <volume>35</volume>
          <fpage>459</fpage>
          <lpage>464</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.35.2.459</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-53">
        <label>Simakova &amp; Arispe (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simakova</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Arispe</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>The cell-selective neurotoxicity of the Alzheimer’s Abeta peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for Abeta toxicity</article-title>
          <source>Journal of Neuroscience</source>
          <issue>50</issue>
          <year iso-8601-date="2007">2007</year>
          <volume>27</volume>
          <fpage>13719</fpage>
          <lpage>13729</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3006-07.2007</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-54">
        <label>Stine et al. (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stine</surname>
              <given-names>WB</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Dahlgren</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Krafft</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>LaDu</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>13</issue>
          <year iso-8601-date="2003">2003</year>
          <volume>278</volume>
          <fpage>11612</fpage>
          <lpage>11622</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M210207200</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-55">
        <label>Teplow (2006)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teplow</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Preparation of amyloid beta-protein for structural and functional studies</article-title>
          <source>Methods in Enzymology</source>
          <year iso-8601-date="2006">2006</year>
          <volume>413</volume>
          <fpage>20</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1016/S0076-6879(06)13002-5</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-56">
        <label>Walsh et al. (1997)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walsh</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Lomakin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Benedek</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Condron</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Teplow</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>35</issue>
          <year iso-8601-date="1997">1997</year>
          <volume>272</volume>
          <fpage>22364</fpage>
          <lpage>22372</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.272.35.22364</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-57">
        <label>Wang et al. (2000)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>D’Andrea</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Shank</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Reitz</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <article-title>beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer’s disease pathology</article-title>
          <source>Journal of Biological Chemistry</source>
          <issue>8</issue>
          <year iso-8601-date="2000">2000</year>
          <volume>275</volume>
          <fpage>5626</fpage>
          <lpage>5632</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.275.8.5626</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-58">
        <label>Wang et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons</article-title>
          <source>Neurodegenerative Diseases</source>
          <issue>1–3</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>7</volume>
          <fpage>56</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="doi">10.1159/000283484</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-59">
        <label>Williams, Day &amp; Serpell (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Serpell</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>The effect of Alzheimer’s Abeta aggregation state on the permeation of biomimetic lipid vesicles</article-title>
          <source>Langmuir</source>
          <issue>22</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>26</volume>
          <fpage>17260</fpage>
          <lpage>17268</lpage>
          <pub-id pub-id-type="doi">10.1021/la101581g</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-60">
        <label>Yoda, Miura &amp; Takeuchi (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Non-electrostatic binding and self-association of amyloid beta-peptide on the surface of tightly packed phosphatidylcholine membranes</article-title>
          <source>Biochemical and Biophysical Research Communications</source>
          <issue>1</issue>
          <year iso-8601-date="2008">2008</year>
          <volume>376</volume>
          <fpage>56</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbrc.2008.08.093</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-61">
        <label>Yu et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Edalji</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Harlan</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Holzman</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Labkovsky</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hillen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Barghorn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ebert</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Miesbauer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Solomon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bartley</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Hajduk</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Olejniczak</surname>
              <given-names>ET</given-names>
            </name>
          </person-group>
          <article-title>Structural characterization of a soluble amyloid beta-peptide oligomer</article-title>
          <source>Biochemistry</source>
          <issue>9</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>48</volume>
          <fpage>1870</fpage>
          <lpage>1877</lpage>
          <pub-id pub-id-type="doi">10.1021/bi802046n</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-62">
        <label>Zagorski &amp; Barrow (1992)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zagorski</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Barrow</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix—-beta-sheet conversion for a homologous, 28-residue, N-terminal fragment</article-title>
          <source>Biochemistry</source>
          <issue>24</issue>
          <year iso-8601-date="1992">1992</year>
          <volume>31</volume>
          <fpage>5621</fpage>
          <lpage>5631</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00139a028</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-63">
        <label>Zagorski et al. (1999)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zagorski</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity</article-title>
          <source>Methods in Enzymology</source>
          <year iso-8601-date="1999">1999</year>
          <volume>309</volume>
          <fpage>189</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="doi">10.1016/S0076-6879(99)09015-1</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
